
Clare Ozawa
Managing Director
Clare joined Versant as Managing Director in 2017, leading investments across the Bay Area and San Diego. She also oversees operations and finance at Inception Sciences. During her tenure, Clare has launched several startups in collaboration with academic researchers and pharmaceutical companies. Previously, she worked at Novartis, managing strategic initiatives for the Pharma Executive Committee.
Investor scope
Investment criteria breakdown.
Investment stages
Series A
Target regions
USA
Canada
Europe
Investment ranges
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Biotech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.